VANCOUVER , Jan. 14, 2013 \/CNW\/ - Abattis Bioceuticals Corp. (the \"Company\" or \"Abattis\") (OTC PINK: ATTBF) (CNSX:FLU), announces the engagement of Andrew Riseman Ph.D. effective January 11, 2013 . Dr. Riseman will be assisting the Company in Applied Biology and Plant Sciences. <\/p>\n
Mr. Mike Withrow , Chief Executive Officer on behalf of the Company, stated, \"We are pleased to have Dr. Riseman join our Abattis team. His expertise in tissue and plant breeding sciences will be a tremendous asset to Abattis; we will apply his knowledge to produce proprietary intellectual property for the company. \" <\/p>\n
Andrew Riseman Ph.D., Associate Professor, Plant Biology and Plant Breeding at UBC stated, I am very excited about this opportunity to work with such a great company to advance botanical sciences in the Medical Marijuana and other medicinal plant breeding sciences, I see Abattis a company with the ability to engineer, grow and extract advanced Pharmaceutical Grade Compounds \"PGC's\" that ensure traceability, consistency in dosing and safety with a target to produce the purest compounds from chosen cultivars.\" <\/p>\n
About Abattis Bioceuticals Corp. Abattis Bioceuticals Corp. is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of producing, licensing and marketing proprietary ingredients and bio-similar compounds for use in Pharmaceuticals, Nutraceutical, Cosmetic and Animal Nutrition markets. The company also has a deep pipeline of proprietary products ready for sale in high growth areas of Functional Foods and Supplements business. For more information, visit the Company's website at http:\/\/www.abattis.com<\/a>. <\/p>\n About Dr. Riseman http:\/\/www.landfood.ubc.ca\/directory\/faculty\/professors-and-instructors\/andrew-riseman<\/a> <\/p>\n ON BEHALF OF THE BOARD <\/p>\n Neither the CNSX Exchange nor its regulations services accepts responsibility for the adequacy or accuracy of this release. <\/p>\n SOURCE: Abattis Bioceuticals Corp. <\/p>\n <\/p>\n See the article here: VANCOUVER , Jan. 14, 2013 \/CNW\/ - Abattis Bioceuticals Corp. (the \"Company\" or \"Abattis\") (OTC PINK: ATTBF) (CNSX:FLU), announces the engagement of Andrew Riseman Ph.D. Continue reading
\nAbattis signs Andrew Riseman, Ph.D. Associate Professor, Applied Biology and Plant Breeding<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"